Tag: Dr. Hepeng Shi

Avistone Biotechnology receives NMPA approval for Vebreltinib in China

businessnewstoday- November 19, 2023

Avistone Biotechnology Co. Ltd., a precision oncology therapeutics company, has announced the conditional approval from the National Medical Products Administration (NMPA) of China for commercializing ... Read More